scispace - formally typeset
M

Matthew R. Young

Researcher at National Institutes of Health

Publications -  62
Citations -  4781

Matthew R. Young is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Carcinogenesis & Tumor promotion. The author has an hindex of 35, co-authored 59 publications receiving 4321 citations. Previous affiliations of Matthew R. Young include Science Applications International Corporation.

Papers
More filters
Journal ArticleDOI

Association of Arsenic-Induced Malignant Transformation with DNA Hypomethylation and Aberrant Gene Expression

TL;DR: Results indicate arsenic can act as a carcinogen by inducing DNA hypomethylation, which in turn facilitates aberrant gene expression, and they constitute a tenable theory of mechanism in arsenic carcinogenesis.
Journal ArticleDOI

Rapid Cancer Detection by Topically Spraying a γ-Glutamyltranspeptidase–Activated Fluorescent Probe

TL;DR: A rapidly activatable, cancer-selective fluorescence imaging probe that fluoresces upon cleavage by a cancer-specific enzyme and can be used during surgical or endoscopic tumor removal procedures, and several other aminopeptidase–based reagents identified by the authors could help surgeons to track down tiny tumors dispersed throughout body cavities.
Journal ArticleDOI

Targeting AMPK for cancer prevention and treatment

TL;DR: The role of AMPK in regulating inflammation, metabolism, and other regulatory processes with an emphasis on cancer is reviewed and the potential for targeting AMPK to treat various types of cancer is discussed.
Journal ArticleDOI

Activator protein 1 (AP-1)– and nuclear factor κB (NF-κB)–dependent transcriptional events in carcinogenesis

TL;DR: It is demonstrated that AP-1 and NF-κB are both required for maintaining the transformed phenotypes where inhibition of either activity suppresses transformation response in JB6 cells as well as human keratinocytes and transgenic mouse.